These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. Tobío M, Nolley J, Guo Y, McIver J, Alonso MJ. Pharm Res; 1999 May; 16(5):682-8. PubMed ID: 10350011 [Abstract] [Full Text] [Related]
6. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers. Gupta RK, Alroy J, Alonso MJ, Langer R, Siber GR. Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673 [Abstract] [Full Text] [Related]
7. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B. Pharm Res; 1998 Jul; 15(7):1103-10. PubMed ID: 9688067 [Abstract] [Full Text] [Related]
8. Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents. Audran R, Men Y, Johansen P, Gander B, Corradin G. Pharm Res; 1998 Jul; 15(7):1111-6. PubMed ID: 9688068 [Abstract] [Full Text] [Related]
10. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Jung T, Kamm W, Breitenbach A, Hungerer KD, Hundt E, Kissel T. Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276 [Abstract] [Full Text] [Related]
11. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine. Schwendeman SP, Costantino HR, Gupta RK, Tobio M, Chang AC, Alonso MJ, Siber GR, Langer R. Dev Biol Stand; 1996 Mar; 87():293-306. PubMed ID: 8854030 [Abstract] [Full Text] [Related]
15. Determinants of release rate of tetanus vaccine from polyester microspheres. Alonso MJ, Cohen S, Park TG, Gupta RK, Siber GR, Langer R. Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256 [Abstract] [Full Text] [Related]
16. Improved immunogenicity of a core-coated tetanus toxoid delivery system. Tobío M, Schwendeman SP, Guo Y, McIver J, Langer R, Alonso MJ. Vaccine; 1999 Nov 12; 18(7-8):618-22. PubMed ID: 10547420 [Abstract] [Full Text] [Related]
17. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. Chang AC, Gupta RK. J Pharm Sci; 1996 Feb 12; 85(2):129-32. PubMed ID: 8683435 [Abstract] [Full Text] [Related]
18. Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. Xing DK, Crane DT, Bolgiano B, Corbel MJ, Jones C, Sesardic D. Vaccine; 1996 Sep 12; 14(13):1205-13. PubMed ID: 8961506 [Abstract] [Full Text] [Related]
19. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres. Xing DK, McLellan K, Corbel MJ, Sesardic D. Biologicals; 1996 Mar 12; 24(1):57-65. PubMed ID: 8733602 [Abstract] [Full Text] [Related]